The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million ...

Persistent cold hands could signal Peripheral Artery Disease PAD linked to high cholesterol Learn symptoms risk factors complications and prevention tips ...

Semaglutide, a glucagon-like peptide 1 (GLP-1) agonist, significantly improved maximal walking distance in people with ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

STRIDE investigator Marc Bonaca, MD, MPH, University of Colorado School of Medicine, highlights how the data could provide insight into peripheral artery disease and type 2 diabetes treatment options.

Lilly's drug is one of several being tested to treat high Lp(a), a risk factor for heart disease that affects an estimated ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

The Delhi High Court recently underscored the importance of disability pension for soldiers who suffer the stresses and ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated, with fewer ...